850 related articles for article (PubMed ID: 17189415)
21. Decreased tumor surveillance after adoptive T-cell therapy.
Matter M; Pavelic V; Pinschewer DD; Mumprecht S; Eschli B; Giroglou T; von Laer D; Ochsenbein AF
Cancer Res; 2007 Aug; 67(15):7467-76. PubMed ID: 17671217
[TBL] [Abstract][Full Text] [Related]
22. Induction of protective cytotoxic T cells with viral proteins.
Bachmann MF; Kündig TM; Freer G; Li Y; Kang CY; Bishop DH; Hengartner H; Zinkernagel RM
Eur J Immunol; 1994 Sep; 24(9):2228-36. PubMed ID: 8088338
[TBL] [Abstract][Full Text] [Related]
23. Use of a high-affinity peptide that aborts MHC-restricted cytotoxic T lymphocyte activity against multiple viruses in vitro and virus-induced immunopathologic disease in vivo.
Oldstone MB; von Herrath M; Lewicki H; Hudrisier D; Whitton JL; Gairin JE
Virology; 1999 Apr; 256(2):246-57. PubMed ID: 10191190
[TBL] [Abstract][Full Text] [Related]
24. CTL induction by cross-priming is restricted to immunodominant epitopes.
Pavelic V; Matter MS; Mumprecht S; Breyer I; Ochsenbein AF
Eur J Immunol; 2009 Mar; 39(3):704-16. PubMed ID: 19189311
[TBL] [Abstract][Full Text] [Related]
25. Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.
Sutherland R; Buchegger F; Schreyer M; Vacca A; Mach JP
Cancer Res; 1987 Mar; 47(6):1627-33. PubMed ID: 3545451
[TBL] [Abstract][Full Text] [Related]
26. Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments.
Buchegger F; Pfister C; Fournier K; Prevel F; Schreyer M; Carrel S; Mach JP
J Clin Invest; 1989 May; 83(5):1449-56. PubMed ID: 2708519
[TBL] [Abstract][Full Text] [Related]
27. Antitumor x anti-CD3 bifunctional antibodies redirect T-cells activated in vivo with staphylococcal enterotoxin B to neutralize pulmonary metastases.
Penna C; Dean PA; Nelson H
Cancer Res; 1994 May; 54(10):2738-43. PubMed ID: 8168104
[TBL] [Abstract][Full Text] [Related]
28. Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responses.
Kudo-Saito C; Schlom J; Hodge JW
Clin Cancer Res; 2005 Mar; 11(6):2416-26. PubMed ID: 15788693
[TBL] [Abstract][Full Text] [Related]
29. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
[TBL] [Abstract][Full Text] [Related]
30. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.
van der Most RG; Sette A; Oseroff C; Alexander J; Murali-Krishna K; Lau LL; Southwood S; Sidney J; Chesnut RW; Matloubian M; Ahmed R
J Immunol; 1996 Dec; 157(12):5543-54. PubMed ID: 8955205
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
Schwegler C; Dorn-Beineke A; Nittka S; Stocking C; Neumaier M
Cancer Res; 2005 Mar; 65(5):1925-33. PubMed ID: 15753392
[TBL] [Abstract][Full Text] [Related]
32. Viral escape at the molecular level explained by quantitative T-cell receptor/peptide/MHC interactions and the crystal structure of a peptide/MHC complex.
Tissot AC; Ciatto C; Mittl PR; Grütter MG; Plückthun A
J Mol Biol; 2000 Sep; 302(4):873-85. PubMed ID: 10993729
[TBL] [Abstract][Full Text] [Related]
33. Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor alpha.
Robert B; Mach JP; Mani JC; Ychou M; Folli S; Artus JC; Pèlegrin A
Cancer Res; 1996 Oct; 56(20):4758-65. PubMed ID: 8840995
[TBL] [Abstract][Full Text] [Related]
34. Quantification of epitope-specific MHC class-II-restricted T cells following lymphocytic choriomeningitis virus infection.
Kamperschroer C; Quinn DG
Cell Immunol; 1999 May; 193(2):134-46. PubMed ID: 10222055
[TBL] [Abstract][Full Text] [Related]
35. [Viral antigen induced autoimmunity: an animal model for diabetes mellitus type I].
Hengartner H
Verh Dtsch Ges Pathol; 1994; 78():177-9. PubMed ID: 7533982
[TBL] [Abstract][Full Text] [Related]
36. Improved immunotherapy of a recombinant carcinoembryonic antigen vaccinia vaccine when given in combination with interleukin-2.
McLaughlin JP; Schlom J; Kantor JA; Greiner JW
Cancer Res; 1996 May; 56(10):2361-7. PubMed ID: 8625312
[TBL] [Abstract][Full Text] [Related]
37. Anti-tumor activity of class II MHC antigen-restricted cloned autoreactive T cells. II. Novel immunotherapy of B16 melanomas by local and systemic adoptive transfer.
Shiohara T; Moellmann G; Jacobson K; Kuklinska E; Ruddle NH; Lerner AB
J Immunol; 1987 Mar; 138(6):1979-86. PubMed ID: 3493292
[TBL] [Abstract][Full Text] [Related]
38. Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor--secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors.
Li B; VanRoey M; Wang C; Chen TH; Korman A; Jooss K
Clin Cancer Res; 2009 Mar; 15(5):1623-34. PubMed ID: 19208793
[TBL] [Abstract][Full Text] [Related]
39. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
[TBL] [Abstract][Full Text] [Related]
40. Human T cells targeted with anti-T3 cross-linked to antitumor antibody prevent tumor growth in nude mice.
Titus JA; Garrido MA; Hecht TT; Winkler DF; Wunderlich JR; Segal DM
J Immunol; 1987 Jun; 138(11):4018-22. PubMed ID: 3108382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
